Synthetic Biology Market Forecast: $61.6 Billion by 2029, Growing at 26.1% CAGR [Yahoo! Finance]
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Yahoo! Finance
Boston, Dec. 05, 2024 (GLOBE NEWSWIRE) -- According to the latest BCC Research study Synthetic Biology: Global Markets, demand for synthetic biology is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029. This study of the synthetic biology market covers core products such as oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, and production systems, alongside enabling technologies like DNA sequencing, DNA synthesis, gene editing, and bioinformatics. It also examines enabled technologies in the healthcare, industrial chemicals, consumer products and agriculture sectors, among others. The market is analyzed by segment, including DNA sequencing, gene editing, and synthetic biology foundries, with a focus on end-user industries. The study provides market forecasts from 2024 to 2029, with regional of the markets in covering North Am
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Agilent to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Agilent Technologies, Inc. (NYSE: A) had its price target raised by analysts at Citigroup Inc. to $165.00. They now have a "buy" rating on the stock.MarketBeat
- Genomics in Cancer Care: North American Market Growth Forecasts and Business Opportunities, 2024-2031 [Yahoo! Finance]Yahoo! Finance
- Preimplantation Genetic Testing Market to hit USD 1.7 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Agilent Technologies, Inc. (NYSE: A) had its price target lowered by analysts at Bank of America Co. from $153.00 to $150.00. They now have a "neutral" rating on the stock.MarketBeat
A
Earnings
- 11/25/24 - Beat
A
Sec Filings
- 12/20/24 - Form 10-K
- 12/13/24 - Form 8-K
- 12/3/24 - Form 4
- A's page on the SEC website